Repligen (RGEN -0.3%) shareholder Ronald L. Chez says that after speaking to Board Chairperson...

|About: Repligen Corporation (RGEN)|By:, SA News Editor

Repligen (RGEN -0.3%) shareholder Ronald L. Chez says that after speaking to Board Chairperson Karen Dawes, he plans to call as special meeting to discuss reducing the number of shares outstanding in the company and other strategic alternatives for the company on the back of recent developments in its new drug application for RG1068.